Tagged gruticibart
Press Release
Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
Presentation to include clinical data from a phase 2 study of Gruticibart (AB023), a factor XI-targeted antibody being developed for the treatment and prevention of thrombosis and inflammation
Read More